Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.48 M
About PONIARD PHARMACEUT
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of oncology products. The company was founded in 1984 and is headquartered in Seattle, WA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PARD is 0.000100 USD — it hasn't changed in the past 24 hours. Watch PONIARD PHARMACEUT stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PONIARD PHARMACEUT stocks are traded under the ticker PARD.
PARD reached its all-time high on Mar 6, 2000 with the price of 16,800.000000 USD, and its all-time low was 0.000001 USD and was reached on Dec 23, 2021. View more price dynamics on PARD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PARD stock is 0.00% volatile and has beta coefficient of 254.59. Track PONIARD PHARMACEUT stock price on the chart and check out the list of the most volatile stocks — is PONIARD PHARMACEUT there?
Yes, you can track PONIARD PHARMACEUT financials in yearly and quarterly reports right on TradingView.
PONIARD PHARMACEUT is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
No, PARD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PARD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PONIARD PHARMACEUT stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PONIARD PHARMACEUT technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PONIARD PHARMACEUT stock shows the sell signal. See more of PONIARD PHARMACEUT technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.